Hikma Pharmaceutical | HIK - Ebitda

Prix De L'Action
1,465.00
Variation Quotidienne
-2.00 -0.14%
Mensuellement
4.46%
Annuel
-29.43%
Q2 Prévisions
1,414.37




Ebitda Changement Date
Almirall EUR 114.07M 60.37M 2025-12
argenx SE USD 404.12M 17.08M 2025-12
AstraZeneca USD 5.67B 1.29B 2026-03
Autolus Therapeutics Ltd USD -70.08M 11.23M 2025-09
Bayer EUR 4.45B 2.49B 2026-03
Fresenius EUR 951M 283M 2026-03
Genmab DKK 186M 291M 2025-12
GlaxoSmithKline GBP 2.77B 1.65B 2026-03
GRIFOLS EUR 347.45M 210K 2025-12
Hikma Pharmaceutical USD 369M 84M 2024-12
Lakefront Biotherapeutics EUR -63.7M 624.2M 2026-03
Lonza CHF 1.01B 54M 2025-12
Merck EUR 1.53B 87M 2026-03
Orion EUR 130.4M 212.6M 2026-03
Recordati EUR 283.58M 36.43M 2026-03
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 3.31B 3.65B 2026-03
UCB EUR 1.6B 570M 2025-12